Stryker Licenses ArthroCare Coblation Technology Following Serfas Launch
This article was originally published in The Gray Sheet
Executive Summary
Stryker Corp. agreed to license ArthroCare's Coblation radiofrequency arthroscopy technology just days after its mid-June launch of the competing Serfas arthroscopy product in order to head-off a patent infringement suit, ArthroCare says.